News
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
The study found the program was more than 85% effective in reducing infant hospitalizations, emergency-room consultations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback